Nacubactam

N/A

Report date: 2026/03/20 20:03:07
NMEQIDP

Base Information

Drug NameNacubactam
Drug Alias NameRG-6080OP-0595RO-7079901FPI-1459
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsRenal InsufficiencyPyelonephritisUrinary Tract Infections +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[21] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMeiji Seika Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesMeiji Seika Pharmatech Co LtdNa Pharma LtdShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsPyelonephritisUrinary Tract InfectionsIntraabdominal Infections +[6] 
Inactive IndicationsRenal InsufficiencyBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A